Ze‐Xiao Lin

998 total citations
23 papers, 693 citations indexed

About

Ze‐Xiao Lin is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Ze‐Xiao Lin has authored 23 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Ze‐Xiao Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Ze‐Xiao Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Ze‐Xiao Lin collaborates with scholars based in China and Hong Kong. Ze‐Xiao Lin's co-authors include Weicheng Liang, Qi Zhang, Xingyang Xue, Zhijie Feng, Wei Qi, Cuicui Xiao, Shitao Rao, Dan‐Yun Ruan, Xing Li and Xiaokun Ma and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Annals of the Rheumatic Diseases.

In The Last Decade

Ze‐Xiao Lin

22 papers receiving 686 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ze‐Xiao Lin 234 196 181 135 126 23 693
Cuicui Xiao 238 1.0× 277 1.4× 133 0.7× 98 0.7× 121 1.0× 32 781
Birte Möhlendick 155 0.7× 134 0.7× 217 1.2× 77 0.6× 162 1.3× 32 502
Chuanwu Zhu 146 0.6× 158 0.8× 110 0.6× 282 2.1× 82 0.7× 69 643
Yuncheng Li 171 0.7× 215 1.1× 120 0.7× 61 0.5× 136 1.1× 45 546
Lanhua Tang 168 0.7× 257 1.3× 127 0.7× 205 1.5× 131 1.0× 18 669
Yuhu Song 77 0.3× 273 1.4× 106 0.6× 157 1.2× 53 0.4× 49 651
Wai‐Man Wong 208 0.9× 133 0.7× 215 1.2× 175 1.3× 46 0.4× 25 972
Yuhsaku Kanoh 48 0.2× 203 1.0× 97 0.5× 94 0.7× 67 0.5× 43 450
Yi Wei 35 0.1× 209 1.1× 122 0.7× 94 0.7× 108 0.9× 42 622
Wanhua Ren 89 0.4× 169 0.9× 144 0.8× 150 1.1× 120 1.0× 43 579

Countries citing papers authored by Ze‐Xiao Lin

Since Specialization
Citations

This map shows the geographic impact of Ze‐Xiao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze‐Xiao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze‐Xiao Lin more than expected).

Fields of papers citing papers by Ze‐Xiao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze‐Xiao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze‐Xiao Lin. The network helps show where Ze‐Xiao Lin may publish in the future.

Co-authorship network of co-authors of Ze‐Xiao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ze‐Xiao Lin. A scholar is included among the top collaborators of Ze‐Xiao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze‐Xiao Lin. Ze‐Xiao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Jufeng, et al.. (2022). Analysis of the lncRNA–miRNA–mRNA Network Reveals a Potential Regulatory Mechanism of EGFR-TKI Resistance in NSCLC. Frontiers in Genetics. 13. 851391–851391. 12 indexed citations
3.
Li, Wei, Ze‐Xiao Lin, Sidong Xie, et al.. (2022). Complete Response With Cetuximab-Based Treatment of Metastatic Colorectal Cancers: Two Case Reports and Literature Review. Frontiers in Oncology. 12. 798515–798515. 3 indexed citations
4.
Liang, Weicheng, Zhijie Feng, Shitao Rao, et al.. (2020). Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. 69(6). 1141–1143. 272 indexed citations
5.
Liang, Weicheng, Ze‐Xiao Lin, Cong Du, Dongbo Qiu, & Qi Zhang. (2020). mRNA modification orchestrates cancer stem cell fate decisions. Molecular Cancer. 19(1). 38–38. 37 indexed citations
6.
Jia, Changchang, Zhicheng Yao, Ze‐Xiao Lin, et al.. (2020). circNFATC3 sponges miR‐548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression. Journal of Cellular Physiology. 236(2). 1252–1269. 21 indexed citations
7.
Fang, Lin, Ze‐Xiao Lin, Zetao Liao, O. Jin, & Jun Gu. (2020). THU0385 SAFETY OF TOFACITINIB THERAPY IN HBSAG CARRIERS WITH ANKYLOSING SPONDYLITIS: A PROSPECTIVE STUDY. Annals of the Rheumatic Diseases. 79. 427–427. 1 indexed citations
8.
Ma, Xiaokun, Liyuan Zou, Xing Li, et al.. (2019). Inhibition of Autophagy Improves the Efficacy of Abiraterone for the Treatment of Prostate Cancer. Cancer Biotherapy and Radiopharmaceuticals. 34(3). 181–188. 10 indexed citations
9.
10.
Chen, Zhan‐Hong, Xing Li, Dong‐Hao Wu, et al.. (2017). Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters. 14(1). 705–714. 21 indexed citations
11.
Jiang, Nan, Yan‐Fang Xing, Bo Hu, et al.. (2017). Endoplasmic reticulum stress induced LOX‐1+ CD15+ polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinoma. Immunology. 154(1). 144–155. 94 indexed citations
12.
Chen, Xiangwei, Jie Chen, Qu Lin, et al.. (2017). Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans‑arterial chemoembolization therapy. Oncology Letters. 15(1). 855–862. 8 indexed citations
13.
Chen, Zhan‐Hong, Qu Lin, Min Dong, et al.. (2016). Comparison of a new prognostic system and other three current staging systems in predicting the survival rate of patients with HBV-associated advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 34(4_suppl). 347–347. 2 indexed citations
14.
Ruan, Dan‐Yun, Ze‐Xiao Lin, Tiantian Wang, et al.. (2016). Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget. 7(38). 61378–61389. 13 indexed citations
15.
16.
Chen, Zhan‐Hong, Xiaokun Ma, Xing Li, et al.. (2015). Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumor Biology. 37(4). 5265–5273. 5 indexed citations
17.
Wang, Tiantian, Xing Li, Min Dong, et al.. (2015). MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells. Oncology Letters. 10(5). 2691–2698. 25 indexed citations
18.
Wu, Dong‐Hao, Changchang Jia, Jie Chen, et al.. (2014). Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumor Biology. 35(12). 12225–12233. 77 indexed citations
19.
Wu, Xiangyuan, Xing Li, Zhan‐Hong Chen, et al.. (2012). An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biology. 34(2). 909–918. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cuicui Xiao Breakdown of academic impact, for papers by Birte Möhlendick Breakdown of academic impact, for papers by Chuanwu Zhu Breakdown of academic impact, for papers by Yuncheng Li Breakdown of academic impact, for papers by Lanhua Tang Breakdown of academic impact, for papers by Yuhu Song Breakdown of academic impact, for papers by Wai‐Man Wong Breakdown of academic impact, for papers by Yuhsaku Kanoh Breakdown of academic impact, for papers by Yi Wei Breakdown of academic impact, for papers by Wanhua Ren
Rankless by CCL
2026